We design and develop a new class of powerful therapeutics for the treatment of severe diseases. Our plug-and-play platform substantially reduces the random nature of the discovery process to predictably yield ready-to-develop multispecific biotherapeutics for chronic inflammation and cancer.
Cooperation possibilities
Numab offers its discovery and development capabilities to industry partners who are looking for innovative antibody-based products. For further information please contact partnering@numab.com.
-
Oliver Middendorp
